Nualtis Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 33

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 14

  • Investments
  • 1

Nualtis General Information

Description

Manufacturer of oral thin-film drug delivery systems intended to improve pharmaceutical care. The company's technology includes proprietary human and veterinary film platforms, providing contract development, GMP manufacturing, and regulatory support to pharmaceutical partners for the creation of rapid-dissolve therapeutic solutions.

Contact Information

Website
www.nualtis.com
Formerly Known As
Big Flash Corp, Intelgenx Technologies
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 6420 Rue Abrams
  • Saint-Laurent, Quebec H4S 1Y2
  • Canada
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Parent Company
Former Stock Listing
IGXT
Corporate Office
  • 6420 Rue Abrams
  • Saint-Laurent, Quebec H4S 1Y2
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nualtis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nualtis‘s full profile, request access.

Request a free trial

Nualtis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of oral thin-film drug delivery systems intended to improve pharmaceutical care. The company's technology i
Drug Delivery
Saint-Laurent, Canada
33 As of 2026

Caldwell, NJ

Raleigh, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nualtis Competitors (18)

One of Nualtis’s 18 competitors is Lts - Lohmann Therapy Systems, a Corporation company based in Caldwell, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lts - Lohmann Therapy Systems Corporation Caldwell, NJ
BioDelivery Sciences International Private Equity-Backed Raleigh, NC
Haofeng Biotechnology Venture Capital-Backed Taipei, Taiwan
Oramed Pharmaceuticals Corporation New York, NY
Oncimmune Formerly VC-backed Cambridge, MA
You’re viewing 5 of 18 competitors. Get the full list »

Nualtis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nualtis Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nualtis‘s full profile, request access.

Request a free trial

Nualtis Investments (1)

Nualtis’s most recent deal was a Corporate with Pillar5 Pharma. The deal was made on 03-May-2010.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pillar5 Pharma 03-May-2010 Corporate BPO/Outsource Services
To view Nualtis’s complete investments history, request access »

Nualtis Exits (1)

Nualtis’s most recent exit was on 03-May-2010 from Pillar5 Pharma. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Pillar5 Pharma 03-May-2010 Completed
To view Nualtis’s complete exits history, request access »

Nualtis FAQs

  • When was Nualtis founded?

    Nualtis was founded in 2003.

  • Where is Nualtis headquartered?

    Nualtis is headquartered in Saint-Laurent, Canada.

  • What is the size of Nualtis?

    Nualtis has 33 total employees.

  • What industry is Nualtis in?

    Nualtis’s primary industry is Drug Delivery.

  • Is Nualtis a private or public company?

    Nualtis is a Private company.

  • What is the current valuation of Nualtis?

    The current valuation of Nualtis is .

  • What is Nualtis’s current revenue?

    The current revenue for Nualtis is .

  • How much funding has Nualtis raised over time?

    Nualtis has raised $51.9M.

  • Who are Nualtis’s investors?

    AtaiBeckley and Tilray Brands have invested in Nualtis.

  • Who are Nualtis’s competitors?

    Lts - Lohmann Therapy Systems, BioDelivery Sciences International, Haofeng Biotechnology, Oramed Pharmaceuticals, and Oncimmune are some of the 18 competitors of Nualtis.

  • When was Nualtis acquired?

    Nualtis was acquired on 10-Sep-2026.

  • Who acquired Nualtis?

    Nualtis was acquired by COSCIENS Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process